15 October 2008

NICE

Low back pain: consultation on the draft guideline (1st October 2008)
A clinical practice guideline on Low Back Pain is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. The full version describes the evidence and views that have been considered, and sets out the provisional recommendations that have been developed. The (NICE) short version presents the provisional recommendations only with some brief supporting information. Closing date for comments is 26th November 2008.
Draft full guideline
Full guideline appendices (A-F)

Draft NICE guideline
Consultation comments proforma


The revised NICE public health process and methods manuals: consultation on the 2008 drafts (1st October 2008)

The Centre for Public Health Excellence (CPHE) at NICE has carried out a review of the 'Process' and 'Methods' manuals for public health guidance. These documents describe the process and methods for developing public health intervention and programme guidance of NICE. Closing date for comments is 2nd January 2009.
CPHE Methods Manual
CPHE Process Manual

Methods Manual Comments Proforma
Process Manual Comments Proforma


Contraceptive services for socially disadvantaged young people: consultation on the draft scope (13th October 2008)
NICE was asked by the Department of Health to develop guidance on the provision of contraceptive services in appropriate settings for socially disadvantaged young people (up to the age of twenty five). All registered stakeholders for the above public health programme guidance are invited to comment on the draft scope. Closing date for comments is 10th November 2008.
Draft scope
Comments Form

Chronic heart failure (Partial update): draft scope consultation (13th October 2008)

NICE have been asked to develop a clinical practice guideline on Chronic heart failure (partial update) for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Registered stakeholders for this guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline. Closing date for comments is 14th November 2008.
Draft scope
Comments Form


Breast cancer (advanced or metastatic) - lapatinib (appraisal consultation 2) (14th October 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of lapatinib (in combination with capecitabine) and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee met to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of lapatinib. Closing date for comments is 4th November 2008.
Consultation
Evaluation report


Diarrhoea and vomiting in children under 5: consultation on the draft guideline (14th October 2008)
A clinical practice guideline on Diarrhoea and vomiting in children is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. The full version describes the evidence and views that have been considered, and sets out the provisional recommendations that have been developed. The (NICE) short version presents the provisional recommendations only with some brief supporting information. Closing date for comments is 8th December 2008.
Full version
Appendices to full version
NICE version

Comments proforma


Latest implementation tools (8th October 2008)
Stroke
Audit Support

Identifying and supporting people most a risk of dying prematurely
Costing Statement
Slide Set

IPG274 Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy
Audit Support

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir
Cost Template
Audit Support

CG69 Respiratory tract infections
Audit Support

Induction of labour
Audit Support

CG73 Chronic kidney disease
Costing Template
Slide Set

Venous thromboembolism - dabigatran
Costing Statement
Audit Support


Attention deficit hyperactivity disorder (ADHD)
Costing Template
Slide Set

No comments: